Overview
Fimasartan is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension and heart failure. It has been found to be safe when administered with hydrochlorothiazide (a diuretic) in clinical trials. Fimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the brand name Kanarb by Boryung Pharmaceuticals.
Indication
Used for the treatment of hypertension and heart failure .
Associated Conditions
- Hypertension, Essential Hypertension
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/12/20 | Phase 1 | Completed | |||
2024/12/20 | Phase 1 | Completed | |||
2023/12/28 | Phase 1 | Completed | |||
2023/08/23 | Phase 1 | Completed | |||
2023/08/23 | Phase 1 | Completed | |||
2023/07/05 | Phase 3 | Completed | |||
2023/05/26 | Phase 3 | Completed | |||
2022/05/12 | Phase 1 | Completed | |||
2021/12/29 | Phase 4 | Recruiting | |||
2021/10/28 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| KANARB TABLET 60MG | SIN15221P | TABLET | 60mg | 4/24/2017 | |
| KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG | SIN15818P | TABLET, FILM COATED | 60.00 mg | 9/26/2019 | |
| KANARB TABLET 120MG | SIN15222P | TABLET | 120 mg | 4/24/2017 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.